GBP2.21
0.64% today
London, Dec 24, 01:54 pm CET
ISIN
GB00BD3VFW73
Symbol
CTEC
Sector

Convatec Group Stock price

GBP2.21
-0.16 6.82% 1M
-0.18 7.66% 6M
-0.17 7.27% YTD
-0.18 7.64% 1Y
+0.46 26.49% 3Y
+0.42 23.42% 5Y
+0.33 17.52% 10Y
London, Closing price Tue, Dec 24 2024
+0.01 0.64%
ISIN
GB00BD3VFW73
Symbol
CTEC
Sector

Key metrics

Market capitalization GBP4.48b
Enterprise Value GBP5.51b
P/E (TTM) P/E ratio 36.94
EV/FCF (TTM) EV/FCF 29.83
EV/Sales (TTM) EV/Sales 3.15
P/S ratio (TTM) P/S ratio 2.56
P/B ratio (TTM) P/B ratio 3.43
Dividend yield 2.23%
Last dividend (FY23) GBP0.05
Revenue growth (TTM) Revenue growth 0.95%
Revenue (TTM) Revenue GBP1.75b
EBIT (operating result TTM) EBIT GBP246.10m
Free Cash Flow (TTM) Free Cash Flow GBP184.81m
EPS (TTM) EPS GBP0.06
P/E forward 30.36
P/S forward 2.45
EV/Sales forward 3.01
Short interest 54.00%
Show more

Is Convatec Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

Convatec Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Convatec Group forecast:

14x Buy
82%
2x Hold
12%
1x Sell
6%

Analyst Opinions

17 Analysts have issued a Convatec Group forecast:

Buy
82%
Hold
12%
Sell
6%

Financial data from Convatec Group

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
1,748 1,748
1% 1%
100%
- Direct Costs 794 794
1% 1%
45%
954 954
2% 2%
55%
- Selling and Administrative Expenses 447 447
6% 6%
26%
- Research and Development Expense 88 88
8% 8%
5%
420 420
11% 11%
24%
- Depreciation and Amortization 173 173
0% 0%
10%
EBIT (Operating Income) EBIT 246 246
21% 21%
14%
Net Profit 122 122
111% 111%
7%

In millions GBP.

Don't miss a Thing! We will send you all news about Convatec Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

ConvaTec Group Plc operates as holding company, which engages in medical business. Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care and management, continence and critical care, and infusion devices used in the treatment of diabetes and other conditions. The company was incorporated in 1978 and is headquartered in Reading, the United Kingdom.

Head office United Kingdom
CEO Karim Bitar
Employees 10,136
Founded 1978
Website www.convatec.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today